Santen Pharmaceutical Co., Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Santen Pharmaceutical Co., Ltd.'s balance sheet done over the years? Its assets were worth $435,699,000,000 last year, which is more than in the previous period. 30% of Santen Pharmaceutical Co., Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $130,330,000,000, which means an increase by 2% compared compared to last year.
Debt to Assets
| 2015 | 304200000000 | 92.42B | 30.38% |
|---|---|---|---|
| 2016 | 355399000000 | 95.39B | 26.84% |
| 2017 | 322778000000 | 68.89B | 21.34% |
| 2018 | 388463000000 | 100.90B | 25.98% |
| 2019 | 391186000000 | 98.61B | 25.21% |
| 2020 | 408768000000 | 106.20B | 25.98% |
| 2021 | 402353000000 | 95.30B | 23.69% |
| 2022 | 459976000000 | 123.13B | 26.77% |
| 2023 | 421179000000 | 127.88B | 30.36% |
| 2024 | 435699000000 | 130.33B | 29.91% |
SNPHY Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 94.58B | 57.90B | 83.01B | 62.88B | 91.43B | 70.79B | 69.28B | 53.29B | 99.79B | 65.92B |
Short term investments | 379M | 774M | 1.29B | 527M | 452M | 267M | 472M | 333M | 234M | 187M |
Net receivables | 90.53B | 107.16B | 99.59B | 95.99B | 86.99B | 84.61B | 78.65B | 70.97B | 65.99B | 61.70B |
Inventory | 43.18B | 39.35B | 37.14B | 41.57B | 35.28B | 35.23B | 30.63B | 28.50B | 24.99B | 20.13B |
Other current assets | 7.45B | 8.90B | 8.38B | 5.24B | 4.39B | 3.82B | 4.32B | 4.24B | 3.71B | 2.91B |
Total current assets | 236.13B | 213.32B | 229.42B | 206.23B | 218.55B | 194.74B | 183.36B | 157.01B | 194.73B | 150.67B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 71.57B | 66.17B | 56.28B | 39.48B | 35.60B | 31.69B | 29.70B | 28.55B | 27.99B | 29.10B |
Goodwill | 8.30B | 7.38B | 13.71B | 26.85B | 22.12B | 22.71B | 0 | 22.77B | 0 | 6.57B |
Intangible assets | 75.51B | 96.30B | 130.21B | 112.87B | 119.85B | 131.11B | 134.49B | 102.80B | 83.68B | 84.43B |
Long term investments | 33.4B | 42.56B | 40.94B | 40.93B | 32.66B | 31.86B | 35.30B | 29.55B | 44.30B | 34.53B |
Other non-current assets | 10.76B | 1M | 0 | 0 | 0 | 1M | 3.32B | 2.45B | 2.34B | 2.47B |
Total non-current assets | 199.56B | 207.85B | 230.55B | 196.12B | 190.21B | 196.44B | 205.09B | 165.76B | 160.66B | 153.52B |
Total assets | 435.69B | 421.17B | 459.97B | 402.35B | 408.76B | 391.18B | 388.46B | 322.77B | 355.39B | 304.2B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | -3.05B | -13.96B | -2.91B | -5.72B | -500M | 0 | -9.33B | 0 | -11.76B |
Short term debt | 0 | 0 | 13.96B | 2.91B | 5.72B | 500M | 0 | 0 | 0 | 0 |
Total current liabilities | 92.79B | 89.50B | 95.82B | 78.54B | 67.59B | 60.66B | 62.20B | 53.43B | 73.23B | 56.34B |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 12.67B | 2.4B | 1.96B | 3.56B | 0 | 7.59B | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 37.53B | 29.50B | 947M | 1.51B | 1.48B | 1.79B | 25.79B | 7.86B | 18.17B | 36.08B |
Total non-current liabilities | 37.53B | 38.37B | 27.31B | 16.75B | 38.61B | 37.95B | 38.70B | 15.46B | 22.16B | 36.08B |
Total liabilities | 130.33B | 127.88B | 123.13B | 95.30B | 106.20B | 98.61B | 100.90B | 68.89B | 95.39B | 92.42B |